StockSelector.com
  Research, Select, & Monitor Thursday, September 24, 2020 10:34:37 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Athersys Inc$2.00$.094.71%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Athersys Inc vs Chemicals - Major Diversified

Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and immune disorders, pulmonary and other conditions. The company's lead platform product is MultiStem cell therapy, an off the shelf allogeneic stem cell product currently in Phase 3 clinical development for treating ischemic stroke. Based on promising Phase 2 results, this program has received Fast Track and RMAT (equivalent to Breakthrough Therapy for regenerative medicine treatments) designations from the FDA, as well as similar designations in Japan. The company also has an ongoing Phase II clinical study for treating patients with acute myocardial infarction; a planned Phase II for trauma (supported by the DOD).




Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $5.6 Mil $152,519.5 Mil
  Market Cap: $365.4 Mil $309,221.5 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: (76.8%) (13.7%)
  Estimated Revenue: N/A (2.5%)
  Historic Earnings: N/A (6.7%)
  Estimated Earnings: N/A 6.4%
  Stock Price (1 Year): 33.6% 3.0%
  Cash per Share: (37.9%) (2.6%)
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 17.9
  Price-to-Sales: 526.3 N/A
  Price-to-Book: 12.9 3.2
  Dividend Yield: N/A N/A
  Market Cap: $365.4 Mil $30,922.2 Mil
  Operations
  Net Margin: (7,644.0%) 11.7%
  Gross Margin: 100.0% 35.1%
  Return on Equity: (1.9) .1
  Return on Assets: (1.1) .0
  Balance Sheet
  Current Ratio: 2.9 1.6
  Quick Ratio: 2.9 1.1
  Cash Ratio: 2.7 .3
  Debt-to-Equity: .8 1.8
  Interest Coverage: N/A .5
 Technicals
  Relative-Strength Index: 45.2 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $31.68 $74,722.7 Mil
  Air Products & Chemicals, Inc.  (APD) $289.99 $63,479.6 Mil
  Du Pont De Nemours & Co., Inc.  (DD) $54.30 $39,923.9 Mil
  Henkel KGaA  (HENKY) $22.33 $39,130.5 Mil
  Dow Chemical Co.  (DOW) $46.41 $34,554.9 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.